Citizens JMP Reiterates Market Outperform on Oracle, $285 PT
Citizens analyst Patrick Walravens reiterated a Market Outperform rating and $285 price target on Oracle (NYSE: ORCL).
“We maintain our Market Outperform rating and $285 price target on Oracle Corp.
(ORCL) after the stock has fallen 17% YTD vs. an increase of 12% for the Russell 3000, after we conducted due diligence, which showed modest improvement over last quarter (83% positive vs.
76%), and ahead of its F1Q27 earnings report on Thursday after the close, where we expect ORCL to accelerate total revenue to $19B, up 29% vs.
21% last quarter, and OCI revenue to $7.1B, up a whopping 111% vs. 93% last quarter.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
